Gene: TTLL7
Official Full Name: tubulin tyrosine ligase like 7provided by HGNC
Gene Summary: Enables alpha-tubulin binding activity; beta-tubulin binding activity; and tubulin-glutamic acid ligase activity. Involved in protein polyglutamylation. Predicted to be located in 9+0 non-motile cilium. Predicted to be active in ciliary basal body. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12946 | TTLL7 Knockout cell line (HeLa) | Human | TTLL7 | 1:3~1:6 | Negative | Online Inquiry |
KO12947 | TTLL7 Knockout cell line (HCT 116) | Human | TTLL7 | 1:2~1:4 | Negative | Online Inquiry |
KO12948 | TTLL7 Knockout cell line (HEK293) | Human | TTLL7 | 1:3~1:6 | Negative | Online Inquiry |
KO12949 | TTLL7 Knockout cell line (A549) | Human | TTLL7 | 1:3~1:4 | Negative | Online Inquiry |
TTLL7 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to disrupt the expression of the TTLL7 gene. This gene encodes a tubulin polyglutamylation enzyme, which plays a crucial role in the post-translational modification of tubulin proteins, influencing microtubule dynamics and cellular functions. By employing CRISPR/Cas9 technology to create these knockout variants, researchers can effectively study the phenotypic effects and biological pathways affected by the absence of TTLL7, shedding light on its role in cellular processes such as cell cycle regulation, migration, and intracellular transport.
The primary function of the TTLL7 Gene Knockout Cell Lines is to facilitate advanced studies in cell biology and molecular genetics, particularly regarding microtubule regulation and related pathologies. The knockout of TTLL7 leads to significant alterations in microtubule stability and function, making it an invaluable tool for elucidating the mechanisms underlying various disease states, including neurodegenerative disorders and cancer.
Scientifically, these cell lines have tremendous applications in both research and clinical settings. They provide an effective model for high-throughput drug screening, target validation, and understanding the genetic basis of diseases. Researchers can employ these knockout lines to investigate the interactions between tubulin modifications and therapeutic responses, making them critical for the development of novel treatment strategies.
One notable advantage of our TTLL7 Gene Knockout Cell Lines is their consistency in experimental reproducibility, thanks to rigorous quality control measures during their development. Unlike other gene disruption methods that can yield heterogeneous populations, the complete knockout achieved through CRISPR technology ensures a uniform genetic background, delivering reliable data across research studies. Additionally, these cell lines are readily available and adaptable to various laboratory environments, ensuring ease of use for researchers.
For researchers and clinicians focused on unraveling the complexities of cellular mechanisms and their implications in health and disease, the TTLL7 Gene Knockout Cell Lines offer an essential resource that can drive innovation and insights. Our company, with a strong foundation in genetic engineering and cell line development, is committed to providing high-quality biological tools that empower scientific discovery and enhance research outcomes for the global medical and academic communities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.